Life Sciences

Priority Health Provides Members Free Access To Personal Health Companion

GRAND RAPIDS—Priority Health has introduced a new customer benefit—Brook, a personal mobile health companion that provides support in the areas of nutrition, sleep management, general health and COVID-19 information. Brook, developed by the Seattle-based firm Brook Inc., uses artificial intelligence and real-time health expert access to provide 24/7 personalized support for general health concerns and

By |2020-07-12T19:07:51-04:00July 12th, 2020|Life Sciences, Mobile MI|

COVID-19 Update: Should You Fly Commercial?

ANN ARBOR - Infectious disease expert Fred Brown tells you what to do should you want to fly on a commercial aircraft flight to avoid catching COVID-19 and giving it to anyone else. President | Chief Operating Officer Fred Brown Management Consulting C-suite strategy and operations consulting to healthcare providers, insurers and suppliers. • COO

By |2020-06-20T13:56:29-04:00June 18th, 2020|Life Sciences, Life Sciences/Biotech, mitechtv|

New Report Shows Growth In Michigan’s Biotech Sector

ANN ARBOR—The Biotechnology Innovation Organization (BIO), the life science industry’s trade and lobbying group, has released its ninth biennial report, “The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities,” which highlights Michigan as a top state for the biosciences. The report studies the state of the U.S. bioscience industry and its associated innovation

By |2020-06-13T15:17:46-04:00June 13th, 2020|ESD, Life Sciences, Life Sciences/Biotech|

Michigan Health Endowment Fund To Provide $2.95 Million For Telemedicine

LANSING – The Michigan Health Endowment Fund and several funding partners are coming together to provide $2.95 million to help 61 Michigan providers and safety net organizations ramp up telehealth efforts, which can help patients access critical care without putting themselves, their families, or their doctors at risk. While many providers have already planned for

By |2020-04-12T14:05:14-04:00April 12th, 2020|Life Sciences, Life Sciences/Biotech|

Ex-Lions Quarterback Eric Hipple Helping Ex-NFL Players, Veterans Cope With Mental Health Issues

ANN ARBOR - Eric Hipple, who played quarterback for the Detroit Lions and suffered serious head injuries, is now helping former NFL players and Veterans cope with post traumatic stress, and related mental health issues. His advice also is valuable for people now in Lock Down from the COVID-19 pandemic. Ex-Detroit Lions Quarterback Eric

By |2020-04-09T09:13:50-04:00April 8th, 2020|Life Sciences|

Esperion’s New Cholesterol-Busting Drug Hits The Market

ANN ARBOR—After years of development, Nexletol, the new cholesterol-reducer from Ann Arbor’s Esperion Therapeutics Inc., is now on the market and available in pharmacies in the United States. Nexletol uses a new mechanism of action to reduce low-density lipoprotein (LDL-C), the so-called bad cholesterol in the bloodstream, the cholesterol that can cause arterial blockages that

Priority Health Expands Free Telehealth, Home Prescription Delivery

GRAND RAPIDS—In response to the COVID-19 outbreak, Priority Health announced that it will be expanding its existing $0 copay telehealth, also known as virtual care, to include all lines of business through April 30. This means that essentially all of the company’s nearly one million members across commercial, individual, Medicaid and Medicare plans, will now

By |2020-03-29T17:38:30-04:00March 29th, 2020|ESD, IoT, Life Sciences, Life Sciences/Biotech|

Automation Alley Seeks Help From Medical Device Makers Battling COVID-19

TROY—Automation Alley is requesting help from its members identifying suppliers and providers of personal protective equipment and medical supplies in response to the coronavirus pandemic. The survey is sponsored by the National Council of Textile Organization, the Industrial Fabrics Association International, and the Association of the Nonwoven Fabrics Industry. The survey is intended to identify

Esperion Names Pharma CFO To Board

ANN ARBOR—Cholesterol-lowering drug developer Esperino Therapeutics Inc. has appointed Alan Fuhrman as a Class III director, with a term expiring at the 2022 meeting of stockholders. “On behalf of the Lipid Management team and our directors, I am very pleased to welcome Alan to the Esperion board. His extensive financial leadership experience will be extremely

By |2020-03-22T16:02:44-04:00March 22nd, 2020|Life Sciences, Life Sciences/Biotech|

Two Traverse City Companies Team Up To Provide Drive-Through COVID19 Testing Popups

TRAVERSE CITY – Two Traverse City companies are working together to offer drive-through COVID-19 testing centers that would include the tent to house staff and the software that would facilitate testing and samples that would be sent to laboratories to determine if the person tested has coronavirus. Russell Schindler, CEO of SampleServe, has spent more

By |2020-03-18T14:46:17-04:00March 18th, 2020|Featured, Life Sciences, Life Sciences/Biotech|